Posts by Scott Riefler and Michael Flemmens
Seven steps you can take now to support hemp regulation
For those of us working with hemp, November 2025 will be remembered as a wake-up moment. While the timing might have been surprising to some, it is a call for our industry to align and support our regulatory bodies who oversee consumer protection and safety. With the passage of the federal spending, including the Agriculture…
Read MoreMoving towards a kaleidescopic entourage effect in cannabis beverages
If you came to cannabis from smoking and later tried a cannabis beverage, you probably noticed a real difference in how it hits. The effects of smoking feel layered, almost kaleidoscopic–an “entourage effect” of sensations. And while most THC beverages do provide a high, they feel… monotone. That experience isn’t just your imagination. The truth…
Read MoreDeveloping a cannabis beverage? Follow these three pro tips
We live in a very exciting time, when the cannabis beverage market is quickly becoming the next frontier for established alcohol brands. What used to be fringe is now going mainstream. Cannabis products are legal in more markets than ever, while consumers are increasingly shifting gears from alcohol to cannabis. But for beverage brands, there…
Read MoreFour reasons to consider specific gravity weight in your cannabis beverage
For both traditional beverage manufacturers and cannabis brands just getting into drink formulation, there is one aspect of beverage formulation that too often goes unnoticed: its density or specific gravity (SpG). If your brand is getting into cannabis drink production, you must understand how specific gravity drives uniformity of the emulsion, flavor, and sweetness within…
Read MoreFor cannabis brands, nano is a risky play
Why so many cannabis brands are interested in nano The cannabis-infused beverage category is one of the industry’s fastest-growing segments, projected to expand at a 22% CAGR over the next five years. But with opportunity comes challenges. Even with the issues of low bioavailability and varying onset time largely being solved by leading microemulsions providers…
Read More